Back to search
FDAFDA · Food and drugs·Recall number F-1338-2013

Free Form Amino Acids L-Arginine 7 L-Ornithine Complex With Alpha-Lipoic Acid, Promotes Circulation and Muscle Development, Dietary Supplement, 50 Vegetarian Capsules, Gluten Free, Serving Size 2 Capsules. Each product is produced for a specific customer with their distribution information on the label. A general label template was provided with attachment B information. Product is sold in 50 and 100 ct bottles.

Published May 1, 2013 · Recall initiated: April 15, 2013

Summary

FDA records food Class III recall F-1338-2013, published May 1, 2013 and initiated April 15, 2013. Recalling firm: Nexgen Pharma, Inc.; Status: Terminated; Reported quantity: 4571 bottles.; Lot: Lot number 412567. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Nexgen Pharma is recalling a certain lot of dietary supplement L-Arginine L-Ornithine Alpha Lipoic Acid Capsules due to subpotency of the Alpha Lipoic Acid ingredient.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Nexgen Pharma, Inc.
Distributor
Distributed to large and small retailers located nationwide as well as two foreign locations (Canada and Netherlands).
Lot
Lot number 412567.
Risk classification
Class III
Area (FDA)
food
Country
United States

Related recalls

Questions about this recall

Was Free Form Amino Acids L-Arginine 7 L-Ornithine Complex With Alpha-Lipoic Acid, Promotes Circulation and Muscle Development, Dietary Supplement, 50 Vegetarian Capsules, Gluten Free, Serving Size 2 Capsules. Each product is produced for a specific customer with their distribution information on the label. A general label template was provided with attachment B information. Product is sold in 50 and 100 ct bottles. recalled?

Yes. FDA published recall F-1338-2013 on May 1, 2013. Reported hazard: Nexgen Pharma is recalling a certain lot of dietary supplement L-Arginine L-Ornithine Alpha Lipoic Acid Capsules due to subpotency of the Alpha Lipoic Acid ingredient.

What should I do if I have this product?

Voluntary: Firm initiated · Letter